Fernand Labrie

Publications

Page 9 of 26, showing 50 records out of 1263 total, starting on record 401, ending on 450

Publication Category Year
282. Faure, N., Lemay, A., Tolis, G., Labrie, F., Bélanger, A., Fazekas, A.T.A. (1984) Buserelin therapy for prostatic carcinoma, in: Vickery, B.H., Nestor, J.J. et Hafez, E.S.E., eds: LHRH and its analogs: contraceptive and therapeutic applications, Boston, MTP Press, pp 337-349. All publications 1984
283. Labrie, F. (1984) A new approach in the hormonal treatment of prostate cancer: complete instead of partial blockade of androgens. Int. J. Androl., 7: 1-4. All publications 1984
284. Labrie, F. (1984) Résultats exceptionnels d'un nouveau traitement du cancer de la prostate. Interface, 5: 23-25. All publications 1984
285. Labrie, F., Bélanger, A., Dupont, A., Emond, J., Lacourcière, Y., Monfette, G. (1984) Combined treatment with an LHRH agonist and a pure antiandrogen in advanced carcinoma of prostate. Lancet, 2: 1090. All publications 1984
286. Labrie, F., Bélanger, A., Dupont, A., St-Arnaud, R. (1984) Medical castration in men: the first clinical application of LHRH agonists, in: Harrison, R.F. et Thompson, B.J., eds: Fertility and Sterility, MTP Press, pp 25-39. All publications 1984
287. Labrie, F., Dupont, A., Bélanger, A. (1984) Complete androgen neutralization is most important in the treatment of prostate cancer, in: Harrap, K.R., Davis, W. et Calvert, A.H., eds: Cancer Chemotherapy and Selective Drug Development, Martinus Nijihoff Publishing, pp 475-479. All publications 1984
288. Labrie, F., Dupont, A., Bélanger, A. (1984) Un nouveau traitement du cancer de la prostate: la suppression complète des androgènes, in: Mauvais-Jarvis, P. et Schaison, G., eds: Médecine de la reproduction masculine, Flammarion, Presses Université de Montréal, pp 367-383. All publications 1984
289. Labrie, F., Dupont, A., Bélanger, A., Emond, J., Monfette, G. (1984) Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer. Proc. Natl. Acad. Sci. USA, 81: 3861-3863. All publications 1984
290. Labrie, F., Dupont, A., Bélanger, A., Labrie, C., Lacourcière, Y., Emond, J., Monfette, G., Houle, J.G., Girard, J.G., Vallières, A., Bossé, C., Delisle, R. (1984) Dramatic response of prostate cancer to complete antihormonal treatment, in: Bracci, U. et Silverio, F.D., eds: Advances in Urological Oncology and Endocrinology, Rome, Acta Medica, Edizione E Congressi, pp 233-248. All publications 1984
291. Labrie, F., Dupont, A., Bélanger, A., Labrie, C., Lacourcière, Y., Raynaud, J.P., Husson, J.M., Emond, J., Houle, J.G., Girard, J.G., Monfette, G., Paquet, J.P., Vallières, A., Bossé, C., Delisle, R. (1984) Combined antihormonal treatment in prostate cancer: a new approach using an LHRH agonist or castration and an antiandrogen, in: Bresciani, F., King, R.J.B., Lippman, M.E. et Raynaud, J.P., eds: Hormones and cancer 2: Proceedings of the Second International Congress on Hormones and Cancer, New York, Raven Press, pp 533-547. All publications 1984
292. Labrie, F., Dupont, A., Bélanger, A., Lacourcière, Y., Emond, J., Monfette, G. (1984) Combined antiandrogen blockade in adenocarcinoma of the prostate: the first application of a successful new therapeutic principle in hormone-dependent cancer, in: Arvis, G., ed. Second International Forum on Andrology, Expansion Scientifique Française, Paris, pp 163-196. All publications 1984
293. Labrie, F., Dupont, A., Bélanger, A., Lacourcière, Y., Members of LUPCP. (1984) Complete androgen blockade at start of treatment causes a dramatic improvement of survival in advanced prostate cancer, in: Labrie, F., Bélanger, A. et Dupont, A., eds: Proceedings of the International Symposium on LHRH and its analogues: Basic and Clinical Aspects, Excerpta Medica, pp 368-379. All publications 1984
294. Labrie, F., Dupont, A., Bélanger, A., Members of LUPCP (1984) Spectacular response to combined antihormonal treatment in advanced prostate cancer, in: Labrie, F. et Proulx, L., eds: Endocrinology ICS 655, Excerpta Medica, pp 450-453. All publications 1984
295. Labrie, F., Dupont, A., Bélanger, A., St-Arnaud, R., Labrie, C., Members of LUPCP (1984) Medical castration with LHRH agonists and the need for combined treatment with an antiandrogen in prostate cancer, in: McKerns, K.W., ed. Hormonal Control of the Hypothalamic-Pituitary Gonadal Axis, New York, Plenum Press, pp 531-549. All publications 1984
296. Labrie, F., Tremblay, Y., Bélanger, A., Dupont, A. (1984) Medical castration is easily achieved with LHRH agonists, in: Scierra, J.J., ed. 5th International Meeting on Fertility Control, Genoa, Italy, pp 49-60. All publications 1984
297. Lefebvre, F.A., Bélanger, A., Pelletier, G., Labrie, F. (1984) Recovery of gonadal functions in the adult male rat following cessation of 5-month daily treatment with an LHRH agonist. J. Androl., 5: 181-192. All publications 1984
298. Marchetti, B., Labrie, F. (1984) Further characterization of the direct inhibitory effect of LHRH agonists at the testicular level in the rat. J. Steroid Biochem., 20: 339-342. All publications 1984
299. Raynaud, J.P., Bonne, C., Moguilewsky, M., Lefebvre, F.A., Bélanger, A., Labrie, F. (1984) The pure antiandrogen, RU23908 (Anandron), a candidate of choice for the combined antihormonal treatment of prostatic cancer: a review. Prostate, 5: 299-311. All publications 1984
300. Tremblay, Y., Bélanger, A., Labrie, F., Frenette, G., Dubé, J.Y., Tremblay, R.R. (1984) Characteristics of the inhibitory effect of chronic treatment with an LHRH agonist on testicular steroidogenesis in the dog. Prostate, 5: 631-638. All publications 1984
301. Tremblay, Y., Bélanger, A., Lacoste, D., Giasson, M., Labrie, F. (1984) Selective inhibition of spermatogenesis in the presence of normal libido following combined treatment with an LHRH agonist and testosterone in the dog. Contraception, 30: 585-598. All publications 1984
4280. St-Arnaud, R., Chabot, J.-G., Pelletier, G., Labrie, F., Walker, P. (1984) Le facteur de croissance épidermique: structure, localisation, phosphorylation et régulation de son récepteur. Biochimie, 66: 515-530. All publications 1984
4277. Raymond, V., Leung, P.C.K., Veilleux, R., Lefèvre, G., Labrie, F. (1984) LHRH rapidly stimulates phosphatidylinositol metabolism in enriched gonadotrophs. Mol. Cell. Endocrinol., 36: 157-164. All publications 1984
4278. Raynaud, J.P., Azadian-Boulanger, G., Bouton, M.M., Colin, M.C., Faure, N., Ferland-Proulx, L., Gautray, J.P., Husson, J.M., Jolivet, A., Kelly, P.A., Labrie, F., Ojasso, T., Precigoux, G. (1984) RU16117, an orally active estradiol-like weak estrogen. J. Steroid Biochem., 20: 981-993. All publications 1984
4276. Proulx, L., Labrie, F., Veilleux, R., Azadian-Boulanger, G. (1984) Actions of progestins and androgens at the hypothalamo-adenohypophyseal level in the female rat, in: Raynaud, J.P., Ojasoo, T. et Martini, L., eds: Medical Management of Endometriosis, New York, Raven Press, pp 149-161. All publications 1984
4273. Michel, D., Lefevre, G., Labrie, F. (1984) Dexamethasone is a potent stimulator of growth hormone-releasing factor-induced cyclic AMP accumulation in the adenohypophysis. Life Sci., 35: 597-602. All publications 1984
4274. Pelletier, G., Antakly, T., Labrie, F. (1984) The prolactin cell: structure and function, in: Mena, F. et Valderde, C., eds: Frontiers and Perspectives of Prolactin Secretion: A Multidisciplinary Approach, New York, NY. USA, Academic Press, pp 75-92. All publications 1984
4275. Proulx, L., Giguère, V., Côté, J., Labrie, F. (1984) Multiple factors involved in the control of ACTH secretion. J. Endocrinol. Invest., 7: 257-263. All publications 1984
4271. Massicotte, J., Lagacé, L., Labrie, F., Dorrington, J.H. (1984) Modulation of gonadotropin secretion by Sertoli cell inhibin, LHRH and sex steroids. J. Am. Physiol. Soc., 10: E495-E504. All publications 1984
4272. Meunier, H., Proulx, L., Lefèvre, G., Côté, J., Labrie, F. (1984) Catecholaminergic and peptidergic control of rat pars intermedia cell activity, in: Usdin, E., Carlsson, A., Dahlström, A. et Engel, J., eds: Catecholamines. Part B: Neuropharmacology and central nervous system - theoretical aspects, neurology and neurobiology, New York, Alan R. Liss Inc., pp 409-418. All publications 1984
4270. Massicotte, J., Lagacé, L., Godbout, M., Labrie, F. (1984) Modulation of rat pituitary gonadotrophin secretion by porcine granulosa cell "inhibin", LH releasing hormone and sex steroids in rat anterior pituitary cells in culture. J. Endocrinol., 100: 133-140. All publications 1984
4269. Massicotte, J., Lachance, R., Labrie, F. (1984) Modulation of cyclic AMP formation and progesterone secretion by human chorionic gonadotropin, epinephrine, buserelin and prostaglandins in normal or human chorionic gonadotropin desensitized rat immature luteal cells in monolayer culture. J. Steroid Biochem., 21: 217-226. All publications 1984
4267. Lemay, A., Faure, N., Labrie, F., Fazekas, A.T.A. (1984) Postcoital contraception with intranasal Buserelin, in: Vickery, B.H., Nestor, J.J. et Hafez, E.S.E., eds: LHRH and its analogs: advances in reproductive health care, Boston-Lancaster, MTP Press, pp 219-234. All publications 1984
4266. Lemay, A., Faure, N., Labrie, F., Fazekas, A.T.A. (1984) Intranasal LHRH agonist: a post-coital approach. Contraceptive Del System, 4: 107-125. All publications 1984
4262. Labrie, F., Giguère, V., Proulx, L., Lefèvre, G. (1984) Interactions between CRF, epinephrine, vasopressin and glucocorticoids in the control of ACTH secretion. J. Steroid Biochem, 20: 153-160. All publications 1984
4263. Labrie, F., Proulx, L., Giguère, V., Marchetti, B., Godbout, M., Simard, J. (1984) Steroid modulation of LHRH action, in: Martini, L., Gordon, G.S. et Sciarra, F., eds: Steroid Modulation of Neuroendocrine Function of Steroids. Steroids and Bone Metabolism, Amsterdam, North Holland, Biochemical Press, pp 23-37. All publications 1984
4250. Labrie, F., Bélanger, A., Dupont, A. (1984) LHRH and its analogues: basic and clinical aspects, in: Medica, A.E., ed. Proceedings of the International Symposium on LHRH and its Analogues, Quebec City, June 28-30. All publications 1984
4247. Labrie, F. (1984) Expérience institutionnelle dans les domaines de la publication et de la communication scientifique et technique, in: Conseil de la langue française, Québec. L'Avenir du français dans les publications et les communications scientifiques et techniques: Colloque international: Montréal, Hôtel Régence Hyatt, du 1er au 3 nov. 1981: dossier de presse, pp 73-75. All publications 1984
4246. Jezova, D., Jurcovicova, J., Vigas, M., Labrie, F. (1984) Possible mechanisms involved in naloxone-, morphine- and stress-induced ACTH release in rats, in: Usdin, E., Kvetnansky, R. et Axelrod, J., eds: Proceedings of the Third International Symposium on Catecholamines and Other Neurotransmitters in Stress, New York, Gordon and Breach Science Publishers, pp 263-273. All publications 1984
4245. Heisler, S., Veilleux, R., Labrie, F. (1984) PHI stimulates ACTH release from pituitary tumor cell. Mol. Cell. Endocrinol., 35: 183-188. All publications 1984
4243. Faure, N., Lemay, A., Laroche, B., Robert, G., Plante, R., Thabet, M., Roy, R., Jean, C., Forest, J.C., Fazekas, A.T.A. (1984) Labrie, F.,Bélanger, A. et Dupont, A., eds., Clinical response and safety of LHRH agonist treatment in prostatic carcinoma, Québec City, Amsterdam: Excerpta Medica, pp: 312-325, All publications 1984
4242. Faure, N., Ferland-Proulx, L., Gautray, J.P., Husson, J.M., Jolivet, A., Kelly, P.A., Labrie, F., Ojasoo, T., Precigoux, G. (1984) RU16ll7, an orally active estriol-like weak estrogen. J. Steroid Biochem., 20: 981-993. All publications 1984
4241. Di Paolo, T., Daigle, M., Labrie, F. (1984) Effect of estradiol and haloperidol on hypophysectomized rat brain dopamine receptors. Psychoneuroendocrinology, 9: 399-404. All publications 1984
4238. Bédard, P., Boucher, R., Di Paolo, T., Labrie, F. (1984) Interaction between estradiol, prolactin, and striatal dopaminergic mechanisms. Adv. Neurol., 40: 489-495. All publications 1984
271. Labrie, F. (1985) Dreijahrige erfahrungen mit der Kombinations-therapie von Flutamid und einem LHRH-agonisten leuprolide beim Prostatakarzinom. Der Urologe. Ausg. B., B6: 342-343. All publications 1985
272. Labrie, F. (1985) LHRH et ses agonistes: applications thérapeutiques. Médecine/Sciences, 1: 300-305. All publications 1985
273. Labrie, F., Dupont, A., Bélanger, A. (1985) Complete androgen blockade for the treatment of prostate cancer, in: DeVita, V.T., Hellman, S. et Rosenberg, S.A., eds: Important Advances in Oncology, Philadelphia, J.B. Lippincott, pp 193-217. All publications 1985
274. Labrie, F., Dupont, A., Bélanger, A., Giguère, M., Lacourcière, Y., Emond, J., Monfette, G., Bergeron, V. (1985) Combination therapy with Flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival. J. Steroid Biochem., 23: 833-841. All publications 1985
275. Labrie, F., Dupont, A., Bélanger, A., Lachance, R., Giguère, M. (1985) Long-term treatment with luteinizing hormone-releasing hormone agonists and maintenance of serum testosterone to castration concentrations. Br. Med. J. (Clin. Res. Ed.), 291: 369-370. All publications 1985
276. Labrie, F., Dupont, A., Bélanger, A., Lacourcière, Y., Emond, J., Monfette, G., Bergeron, V. (1985) Antiandrogènes et agonistes de la LHRH dans le traitement du cancer de la prostate. Médecine/Sciences, 1: 435-439. All publications 1985
277. Perez, C.A., Fair, W.R., Ihde, D.C., Labrie, F. (1985) Cancer of the prostate, in: De Vita, V.T., Hellman, S. et Rosenberg, C., eds: Cancer: Principles and Practice of Oncology, Philadelphia, J.P. Lippincott, pp 929-964. All publications 1985
<< previous | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 next >>

Biography  |  Publications  |  Scientific Conferences  |  Selected Slide Presentations  |  Awards